Teal is the colour of ovarian cancer awareness, and Teal Day each September is when patients share their experience to help others facing the same choice. Below are anonymised reflections from three women I have treated with cytoreductive surgery + HIPEC — what each of them said they wish they had known before deciding.
On this page
- Patient 1: “Pre-op preparation made the difference”
- Patient 2: “Choose your surgeon, not the hospital brand”
- Patient 3: “Maintenance therapy is part of the plan, not a separate decision”
- What these stories share
Patient 1: “Pre-op preparation made the difference”
Stage 3C primary cytoreduction + HIPEC at age 47. She said the most useful thing she did was 4 weeks of pre-op physiotherapy, dietitian-supervised nutritional optimisation, and pre-emptive iron supplementation. Her hospital stay was 8 days; she was walking unassisted on day 2.
Her message to others: ‘Spend the weeks before surgery preparing your body. The surgery is hard but the recovery is shorter when you arrive strong.’
Patient 2: “Choose your surgeon, not the hospital brand”
Stage 3C interval cytoreduction + HIPEC at age 53. She had been advised by two centres that HIPEC “was not for her” before seeking a third opinion. She said the difference was not the hospital but the surgical team’s volume — they performed 30+ HIPEC procedures annually rather than 5.
Her message: ‘A famous hospital does not mean a famous HIPEC programme. Ask for the volume of cases the team has done this year.’
Patient 3: “Maintenance therapy is part of the plan, not a separate decision”
BRCA-positive, Stage 3A primary surgery + HIPEC at age 41. She is now 3 years out, on PARP inhibitor maintenance, in continuing remission. She said the conversation she had not expected was about maintenance therapy after first-line completion — but it became the most important part of her long-term plan.
Her message: ‘Ask about maintenance therapy at the first consultation. It is not optional information for later.’
What these stories share
- Surgical team volume and experience matter more than hospital prestige.
- Pre-op preparation (physical, nutritional, psychological) reduces recovery time.
- Maintenance therapy planning belongs in the initial consultation, not as an afterthought.
- Second opinions change treatment trajectories in roughly 15–20% of advanced-cancer cases.
For an honest, multi-disciplinary assessment of whether HIPEC is right for you, contact Dr. Nishtha on WhatsApp +91 76988 00333. See also: HIPEC treatment overview, 9 factors that affect HIPEC success.
FAQs
Are patient stories on this site real?
Stories are based on real cases but always anonymised and shared with consent. Identifying details are altered to protect privacy.
Where can I read more long-term outcomes?
Published outcome data from major HIPEC centres including AIIMS, Tata Memorial, ESGO-affiliated centres are available in peer-reviewed journals. Dr. Nishtha’s own academic-work page lists her contributions.
Can I speak with a previous patient before deciding?
With patient consent, we can arrange a brief discussion with a previous patient who has volunteered to share their experience. Request this during your consultation.
How long do most HIPEC patients stay in hospital?
Typical hospital stay is 7–10 days, with 1–3 days in ICU. Enhanced-recovery protocols are reducing this at high-volume centres.
What if I am not eligible for HIPEC?
Many patients who are not optimal HIPEC candidates benefit from cytoreductive surgery alone, PIPAC, or systemic chemotherapy regimens. There is almost always a path.
Reviewed by Dr. Nishtha Tripathi Patel, MBBS, DGO, DNB, Fellowship Gynaecological Oncology, ESGO-certified. For consultations: WhatsApp +91 76988 00333.